(Total Views: 567)
Posted On: 10/07/2021 6:25:49 AM
Post# of 154090
I really love this PR.
Additional staff under the direction of Dr. Recknor. Dr. Ray to focus on HIV BLA.
https://www.cytodyn.com/investors/news-events...tive-vp-of
Additional staff under the direction of Dr. Recknor. Dr. Ray to focus on HIV BLA.
Quote:
CytoDyn Names Chris Recknor, M.D. Senior Executive VP of Clinical Operations to Initiate Two New Clinical Trials for Stroke and Alzheimer’s, While Nitya Ray, Ph.D. is Named CytoDyn’s New COO to Lead CMC and Regulatory Operations Specifically the BLA for HIV
New hires in Bioanalytical Sciences, Biostatistics, Clinical Regulatory, and Clinical Project Management will join the team of Drs. Srinivasan, Recknor, Ray, and Kelly to lead all clinical trials with new CROs
https://www.cytodyn.com/investors/news-events...tive-vp-of
(5)
(0)
